The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clinical features of Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early‐onset Alzheimer's disease: Clinical predictors of institutionalization and death
Heyman, A., Wilkinson, W. E., Hurwitz, B. J., Helms, M. J., Haynes, C. S., Utley, C. M., & Gwyther, L. P. (1987) · Neurology · doi:10.1212/wnl.37.6.980 · Cited by 233
Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease
Beatty, W. W., Salmon, D. P., Butters, N., Heindel, W. C., & Granholm, E. L. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80048-4 · Cited by 165
Cited by
EEG dynamics in patients with Alzheimer's disease
Jeong, J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.001 · Cited by 1,337
Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.004 · Cited by 706
Bioactive Benzofuran derivatives: A review
Khanam, H., & Shamsuzzaman (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.039 · Cited by 554
Mitochondrial oxidative stress in aging and healthspan
Dai, D.-F., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., & Rabinovitch, P. S. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-6 · Cited by 484
Cognitive training for people with mild to moderate dementia
Bahar-Fuchs, A., Martyr, A., Goh, A. M., Sabates, J., & Clare, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013069.pub2 · Cited by 342
Neurodegenerative and neurological disorders by small inhaled particles
Heusinkveld, H. J., Wahle, T., Campbell, A., Westerink, R. H. S., Tran, L., Johnston, H., Stone, V., Cassee, F. R., & Schins, R. P. F. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.07.007 · Cited by 331
Lehmann, C., Koenig, T., Jelic, V., Prichep, L., John, R. E., Wahlund, L.-O., Dodge, Y., & Dierks, T. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.10.023 · Cited by 324
Executive Functions in Alzheimer Disease: A Systematic Review
Guarino, A., Favieri, F., Boncompagni, I., Agostini, F., Cantone, M., & Casagrande, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00437 · Cited by 280
Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Köse, L. P., Gülçin, İ., Gören, A. C., Namiesnik, J., Martinez-Ayala, A. L., & Gorinstein, S. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.05.034 · Cited by 271
Place of Death of Older Persons with Dementia. A Study in Five European Countries
Houttekier, D., Cohen, J., Bilsen, J., Addington‐Hall, J., Onwuteaka‐Philipsen, B. D., & Deliens, L. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02771.x · Cited by 267
Neuronal hyperactivity--A key defect in Alzheimer’s disease?
Busche, M. A., & Konnerth, A. (2015) · BioEssays · doi:10.1002/bies.201500004 · Cited by 266
Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study
Zhao, X., Liu, Y., Wang, X., Liu, B., Xi, Q., Guo, Q., Jiang, H., Jiang, T., & Wang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033540 · Cited by 215
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208
Chakrabarti, S., Kumar Khemka, V., Banerjee, A., Chatterjee, G., Ganguly, A., & Biswas, A. (2015) · Aging and disease · doi:10.14336/ad.2014.002 · Cited by 134
Babiloni, C., Triggiani, A. I., Lizio, R., Cordone, S., Tattoli, G., Bevilacqua, V., Soricelli, A., Ferri, R., Nobili, F., Gesualdo, L., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00047 · Cited by 106
“…clinical manifestation), prodromal (with objective mild cognitive impairment [MCI] but with autonomy substantially preserved), and overt dementia stages, based on in vivo fluid and neuroimaging biomarkers as well as clinical phenotypes of the disease (Förstl and Kurz, 1999; Dubois et al., 2014).”
BackgroundInfluentialSoeda, Y., Saito, M., Maeda, S., Ishida, K., Nakamura, A., Kojima, S., & Takashima, A. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181001 · Cited by 84
Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66
Ocular manifestations of Alzheimer's disease in animal models
Parnell, M., Guo, L., Abdi, M., & Cordeiro, M. F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/786494 · Cited by 56
Adaptive reorganization of cortical networks in Alzheimer’s disease
Dubovik, S., Bouzerda-Wahlen, A., Nahum, L., Gold, G., Schnider, A., & Guggisberg, A. G. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.05.028 · Cited by 34
Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
Pradeep, S., Jain, A. S., Dharmashekara, C., Prasad, S. K., Kollur, S. P., Syed, A., & Shivamallu, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200228 · Cited by 30
The role of microRNA-485 in neurodegenerative diseases
Ryu, I. S., Kim, D. H., Cho, H.-J., & Ryu, J.-H. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0039 · Cited by 25
Assessing Alzheimer’s disease from speech using the i-vector approach
Egas López, J. V., Tóth, L., Hoffmann, I., Kálmán, J., Pákáski, M., & Gosztolya, G. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-26061-3_30 · Cited by 18
Xu, Z., Yang, J., Lau, K. K., Yip, P. S. F., Wong, I. C. K., & Zhang, Q. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200875 · Cited by 1
Metadata
- Authors
- Förstl, H., & Kurz, A.
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 1999-12-16
- Volume
- 249
- Issue
- 6
- Pages
- 288-290
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2374804331
- Cited by
- 442
- References
- 2
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.